Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,654,506
-$1,553,224 QoQ
Shares Held
110,237
-26.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#845
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $126,380,504 across 14 Drug Manufacturers - General names. PFE ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,385 | $43,641,264 | |
| 2 | JNJ |
Johnson & Johnson
|
92,571 | $23,510,256 | |
| 3 | ABBV |
AbbVie Inc.
|
73,209 | $18,422,312 | |
| 4 | MRK |
Merck & Co., Inc.
|
123,237 | $15,835,954 | |
| 5 | AMGN |
Amgen Inc
|
19,733 | $7,145,713 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,562 | $4,492,903 | |
| 7 | NVS |
Novartis AG
|
17,467 | $2,737,428 | |
| 8 | PFE |
Pfizer Inc
This page
|
110,237 | $2,654,506 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,654,506 | 110,237 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,207,730 | 149,848 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,495,288 | 260,855 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,765,765 | 147,793 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,819,015 | 116,296 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,155,623 | 85,068 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,030,879 | 227,323 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,131,655 | 108,212 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $2,649,062 | 94,677 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,161,364 | 77,887 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,046,220 | 71,074 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,247,825 | 158,210 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $5,986,249 | 163,202 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $6,606,213 | 161,917 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,560,410 | 167,065 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $8,833,511 | 168,482 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $8,056,809 | 155,627 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $9,869,262 | 167,134 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,904,215 | 114,025 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,245,834 | 133,959 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,773,845 | 131,765 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $4,596,280 | 124,865 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,891,333 | 106,031 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,386,611 | 103,566 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,351,372 | 102,677 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||